Author Question: A patient will receive buprenorphine (Butrans) as a transdermal patch for pain. What is important to ... (Read 67 times)

shenderson6 · **on:** Jul 23, 2018

A patient will receive buprenorphine (Butrans) as a transdermal patch for pain. What is important to teach this patient about the use of this drug?

a. Avoid prolonged exposure to the sun.
b. Cleanse the site with soap or alcohol.
c. Remove the patch daily at bedtime.
d. Remove hair by shaving before applying the patch.

Question 2

A patient with chronic pain has been receiving morphine sulfate but now has decreased pain. The prescriber changes the medication to pentazocine (Talwin). The nurse will monitor the patient for:

a. euphoria.
b. hypotension.
c. respiratory depression.
d. yawning and sweating.

heyhey123 · **Reply #1 on:** Jul 23, 2018

Answer to Question 1

ANS: A
Patients using the buprenorphine transdermal patch should be cautioned against heat, heating pads, hot baths, saunas, and prolonged sun exposure. The skin should be cleaned with water only. The patch should stay on for 7 days before a new patch is applied. Patients should remove hair by clipping, not shaving.

Answer to Question 2

ANS: D
Pentazocine is an agonist-antagonist opioid, and when given to a patient who is physically dependent on morphine, it can precipitate withdrawal. Yawning and sweating are early signs of opioid withdrawal. Pentazocine does not produce euphoria, hypotension, or respiratory depression.